Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-11-083075
Filing Date
2011-03-30
Accepted
2011-03-30 17:09:15
Documents
4
Period of Report
2011-05-20
Effectiveness Date
2011-03-30

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT ddef14a.htm DEF 14A 313393
2 GRAPHIC g142635g95l79.jpg GRAPHIC 7061
3 GRAPHIC g142635img02.jpg GRAPHIC 171704
4 GRAPHIC g142635pc1.jpg GRAPHIC 258622
  Complete submission text file 0001193125-11-083075.txt   917693
Mailing Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021
Business Address 8001 ARISTA PLACE SUITE 200 BROOMFIELD CO 80021 720-940-2200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-22873 | Film No.: 11722865
SIC: 2835 In Vitro & In Vivo Diagnostic Substances